VALIDATED LC-MS/MS METHOD FOR THE DETERMINATION OF TADALAFIL – A COMPETITIVE PHOSPHODIESTERASE 5 INHIBITOR (PDE5) – FROM HUMAN PLASMA
DOI:
https://doi.org/10.24193/subbchem.2019.2.44Keywords:
tadalafil, phosphodiesterase 5 inhibitor, method validation, bioequivalence trial, LC-MS/MSAbstract
The purpose of this study was the development and validation of an LC-MS/MS method, for the determination of tadalafil from human plasma. The sample workup involved a simple protein precipitation procedure. A core/shell type analytical column (50×2,1 mm, 2.6 Å) was used with C18 stationary phase. The mobile phase consisting of 30% acetonitril and 70% water provided good peak shape, accuracy and precision (stable ionization). The mass spectrometer was operated in positive electrospray ionization mode for analyte and internal standard. The following parameters were evaluated for validation purpose: selectivity, sensitivity, matrix effect, anticoagulant effect, linearity, precision and accuracy, recovery, short and long term analyte/IS stability in solvent/matrix and carryover. The validated calibration range was 22.2-1111.3 ng/ml. The correlation coefficient R2 was at least 0.9995 in all validation batches. The validated method has been successfully used for the evaluation of bioequivalence of generic tadalafil 20 mg formulations.
References
https://www.rxlist.com/cialis-drug.htm: CIALIS (tadalafil) Tablets; Viewed: 14.03.2019)
S. T. Forgue, B. E. Patterson, A. W. Bedding, C. D. Payne, D. L. Phillips, R. E. Wrishko, M. I. Mitchell, Br. J. Clin. Pharmacol., 2005, 61, 280.
N.V.S. Ramakrishna, K.N. Vishwottam, S. Puran, M. Koteshwara, S. Manoj, M. Santosh, J. Chidambara, S. Wishu, B. Sumatha, J. Chromatogr. B., 2004, 809, 243.
Bo Ma, Xuejun Shang, Qi Zhang, Jing Li, Yinhui Liu, Xiaomei Cao, Qiuyu Xu, J. Pharm. Biomed. Anal., 2013, 77, 149.
J. H. Lee, J.-H. Oh, Y.-J. Lee, Arch. Pharm. Res., 2013, 77, 457.
J.-M. Lee, J. Hong, H. B. Oh, B. Moon, Bull. Korean Chem. Soc., 2017, 39, 190.
K. Hasegawa, O. Suzuki, K. Gonmori, I. Yamagishi, H. Nozawa, K. Watanabe, Forensic Toxicol., 2012, 30, 25.
A. Bhadoriya, B. Dasandi, D. Parmar, P. A. Shah, P. S. Shrivastav, J. Pharm. Anal., 2018, 8, 271.
P. Nagaraju, B. Kodali, P. V. Datla, J. Pharm. Biomed. Anal., 2018, 152, 215.
L. Wang, Y. Wang, Y. Chai, Y. Kang, C. Suna, S. Zenga, J. Mass Spectrom., 2017, 52, 411.
Y. Zhang, Z. Huang, L. Ding, H. Yan, M. Wang, S. Zhu, J. Sep. Sci., 2010, 33, 2109.
P. Zou, P. Hou, S. Sze-Yin Oh, M.-Y. Low, H.-L. Koh, Rapid Commun. Mass Spectrom., 2006, 20, 3488.
Fachinformation Cialis, Lilly, Stand. Mar. 2017, https://www.fachinfo.de
EMEA/CHMP/EWP/192217/2009 Rev. 1 Corr. 2** Guideline on validation of bioanalytical method, 21 July 2011 (Updated 03/06/2015).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Studia Universitatis Babeș-Bolyai Chemia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
